Case report and review of the perinatal implications of maternal lithium use

American Journal of Obstetrics and Gynecology

Volumn 187, Issue 1, 2002, Pages 245-249

  Pinelli, Janet M ^a   Symington, Amanda J ^b   Cunningham, Kathryn A ^b   Paes, Bosco A ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Complications; Maternal lithium; Perinatal

Indexed keywords

LITHIUM;

ADULT; ARTICLE; CASE REPORT; CYANOSIS; DEPRESSION; DRUG EFFECT; EBSTEIN ANOMALY; FEMALE; HUMAN; HYPOGLYCEMIA; LETHARGY; MUSCLE HYPOTONIA; NEPHROGENIC DIABETES INSIPIDUS; PERINATAL PERIOD; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; THYROID DISEASE;

EID: 0036074285     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.123610     Document Type: Article

References (43)

1. Lithium treatment during pregnancy, delivery, and lactation: An update
2. Lithium
3. Treating recurrent affective disorders during and after pregnancy
4. Psychotropic medications in pregnant women: Treatment dilemmas
5. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance
6. Lithium carbonate in obstetrics: Guidelines for clinical use
7. Lithium in pregnancy: A review with recommendations
8. Drugs and the treatment of psychiatric disorders
9. Protocol for the treatment of bipolar affective disorder with lithium
10. A reevaluation of risk of in utero exposure to lithium
11. A case-control study on the association between first trimester exposure to lithium and Ebstein's anomaly
12. Lithium toxicity in a newborn
13. Lithium toxicity in a neonate
14. Nephrogenic diabetes insipidus in transplacental lithium intoxication
15. Polyhydramnios with maternal lithium treatment
16. Maternal lithium and neonatal Ebstein's anomaly: Evaluation with cross-sectional echocardiography
17. Prenatal echocardiographic screening for Ebstein's anomaly for mothers on lithium therapy
18. Cardiovascular malformations with lithium use during pregnancy
19. Psychotropic drug use during pregnancy: Weighing the risks
20. Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester
21. Effects of lithium on the kidney
22. The historical background to lithium research and therapy
23. Lithium carbonate intake during pregnancy leading to large goiter in a premature infant
24. Lithium toxicity in the newborn
25. Lithium carbonate therapy during pregnancy: Apparent lack of effect upon the fetus
26. Neonatal lithium toxicity as a result of maternal toxicity
27. A possible association between neonatal jaundice and long-term maternal lithium ingestion
28. Ebstein's anomaly of the tricuspid valve associated with prenatal exposure to lithium carbonate
29. An assessment of lithium using the IEHR evaluative process for assessing human developmental and reproductive toxicity of agents
30. Lithium use during pregnancy
31. Persistent pulmonary hypertension after lithium intoxication in the newborn
32. Tricuspid valve regurgitation and lithium carbonate toxicity in a newborn infant
33. Toxic effects of lithium in newborn infants: A commentary
34. Atrial flutter in the newborn resulting from maternal lithium ingestion
35. Maternal lithium therapy and polyhydramnios
36. Transplacental lithium poisoning: Irreversible inhibition of fetal thyroid
37. Effects of maternal lithium therapy in a newborn infant
38. Problems of lithium maintenance treatment during pregnancy, delivery and lactation
39. Side effects in the neonate from psychotrophic agents excreted through breast-feeding
40. The rational use of psychotropic drugs in pregnancy and postpartum
41. The transfer of drugs and other chemicals into human milk
42. What happened later to the lithium babies: A follow-up study of children born without malformations